Sfoglia per Autore
Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation.
2004 ARPINATI M; CHIRUMBOLO G; URBINI B; BONIFAZI F; BANDINI G; SAUNTHARARAJAH Y; ZAGNOLI A; STANZANI M; FALCIONI S; PERRONE G; TURA S; BACCARANI M.; RONDELLI D.
Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytes.
2006 Catani L.; Fagioli M.E.; Tazzari P.L.; Ricci F.; Curti A.; Rovito M.; Preda P.; Chirumbolo G.; Amabile M.; Lemoli R.M.; Tura S.; Conte R.; Baccarani M.; Vianelli N.
Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors.
2007 Arpinati M; Chirumbolo G; Saunthararajah Y; Stanzani M; Bonifazi F; Bandini G; Baccarani M; Rondelli D.
Increased donor CD86+CD14+ cells in the bone marrow and peripheral blood of patients with chronic graft-versus-host disease.
2008 Arpinati M; Chirumbolo G; Marzocchi G; Baccarani M; Rondelli D.
Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade).
2009 M. Arpinati; G. Chirumbolo; B. Nicolini; C. Agostinelli; D. Rondelli.
Synergism through WEE1 and CHK1 inhibition in acute lymphoblastic leukemia
2019 Di Rora A.G.L.; Bocconcelli M.; Ferrari A.; Terragna C.; Bruno S.; Imbrogno E.; Beeharry N.; Robustelli V.; Ghetti M.; Napolitano R.; Chirumbolo G.; Marconi G.; Papayannidis C.; Paolini S.; Sartor C.; Simonetti G.; Yen T.J.; Martinelli G.
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma
2020 Tolomelli, Giulia; Mancuso, Katia; Tacchetti, Paola; Patriarca, Francesca; Galli, Monica; Pantani, Lucia; Zannetti, Beatrice; Motta, Maria Rosa; Rizzi, Simonetta; Dan, Elisa; Sinigaglia, Barbara; Giudice, Valeria; Olmo, Andrea; Arpinati, Mario; Chirumbolo, Gabriella; Fanin, Renato; Lewis, Russell E; Paris, Laura; Bonifazi, Francesca; Cavo, Michele; Curti, Antonio; Lemoli, Roberto M
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma
2020 Tolomelli G.; Mancuso K.; Tacchetti P.; Patriarca F.; Galli M.; Pantani L.; Zannetti B.; Motta M.R.; Rizzi S.; Dan E.; Sinigaglia B.; Giudice V.; Olmo A.; Arpinati M.; Chirumbolo G.; Fanin R.; Lewis R.E.; Paris L.; Bonifazi F.; Cavo M.; Curti A.; Lemoli R.M.
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant
2021 Papayannidis C.; Sartor C.; Dominietto A.; Zappone E.; Arpinati M.; Marconi G.; Cristiano G.; Nanni J.; Parisi S.; Barbato F.; Paolini S.; Soverini S.; Terragna C.; Robustelli V.; Testoni N.; Chirumbolo G.; Curti A.; Cavo M.; Bonifazi F.
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters
2022 Parisi, Sarah; Ruggeri, Loredana; Dan, Elisa; Rizzi, Simonetta; Sinigaglia, Barbara; Ocadlikova, Darina; Bontadini, Andrea; Giudice, Valeria; Urbani, Elena; Ciardelli, Sara; Sartor, Chiara; Cristiano, Gianluca; Nanni, Jacopo; Zannoni, Letizia; Chirumbolo, Gabriella; Arpinati, Mario; Lewis, Russell E.; Bonifazi, Francesca; Marconi, Giovanni; Martinelli, Giovanni; Papayannidis, Cristina; Paolini, Stefania; Velardi, Andrea; Cavo, Michele; Lemoli, Roberto M.; Curti, Antonio
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters
2022 Parisi S.; Ruggeri L.; Dan E.; Rizzi S.; Sinigaglia B.; Ocadlikova D.; Bontadini A.; Giudice V.; Urbani E.; Ciardelli S.; Sartor C.; Cristiano G.; Nanni J.; Zannoni L.; Chirumbolo G.; Arpinati M.; Lewis R.E.; Bonifazi F.; Marconi G.; Martinelli G.; Papayannidis C.; Paolini S.; Velardi A.; Cavo M.; Lemoli R.M.; Curti A.
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment
2022 Sartor C.; Arpinati M.; Chirumbolo G.; Dozza L.; Cristiano G.; Nanni J.; Marconi G.; Robustelli V.; Vigliotta I.; Parisi S.; Terragna C.; Testoni N.; Paolini S.; Martinelli G.; Curti A.; Cavo M.; Papayannidis C.
A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation
2023 Chirumbolo G.; Dicataldo M.; Barone M.; Storci G.; De Matteis S.; Laprovitera N.; Sinigaglia B.; Barbato F.; Maffini E.; Cavo M.; Bonifazi F.; Arpinati M.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation. | ARPINATI M; CHIRUMBOLO G; URBINI B; BONIFAZI F; BANDINI G; SAUNTHARARAJAH Y; ZAGNOLI A; STANZANI ...M; FALCIONI S; PERRONE G; TURA S; BACCARANI M.; RONDELLI D. | 2004-01-01 | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytes. | Catani L.; Fagioli M.E.; Tazzari P.L.; Ricci F.; Curti A.; Rovito M.; Preda P.; Chirumbolo G.; Am...abile M.; Lemoli R.M.; Tura S.; Conte R.; Baccarani M.; Vianelli N. | 2006-01-01 | EXPERIMENTAL HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors. | Arpinati M; Chirumbolo G; Saunthararajah Y; Stanzani M; Bonifazi F; Bandini G; Baccarani M; Ronde...lli D. | 2007-01-01 | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Increased donor CD86+CD14+ cells in the bone marrow and peripheral blood of patients with chronic graft-versus-host disease. | Arpinati M; Chirumbolo G; Marzocchi G; Baccarani M; Rondelli D. | 2008-01-01 | TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade). | M. Arpinati; G. Chirumbolo; B. Nicolini; C. Agostinelli; D. Rondelli. | 2009-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Synergism through WEE1 and CHK1 inhibition in acute lymphoblastic leukemia | Di Rora A.G.L.; Bocconcelli M.; Ferrari A.; Terragna C.; Bruno S.; Imbrogno E.; Beeharry N.; Robu...stelli V.; Ghetti M.; Napolitano R.; Chirumbolo G.; Marconi G.; Papayannidis C.; Paolini S.; Sartor C.; Simonetti G.; Yen T.J.; Martinelli G. | 2019-01-01 | CANCERS | - | 1.01 Articolo in rivista | WEE1.pdf |
| The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma | Tolomelli, Giulia; Mancuso, Katia; Tacchetti, Paola; Patriarca, Francesca; Galli, Monica; Pantani..., Lucia; Zannetti, Beatrice; Motta, Maria Rosa; Rizzi, Simonetta; Dan, Elisa; Sinigaglia, Barbara; Giudice, Valeria; Olmo, Andrea; Arpinati, Mario; Chirumbolo, Gabriella; Fanin, Renato; Lewis, Russell E; Paris, Laura; Bonifazi, Francesca; Cavo, Michele; Curti, Antonio; Lemoli, Roberto M | 2020-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma | Tolomelli G.; Mancuso K.; Tacchetti P.; Patriarca F.; Galli M.; Pantani L.; Zannetti B.; Motta M....R.; Rizzi S.; Dan E.; Sinigaglia B.; Giudice V.; Olmo A.; Arpinati M.; Chirumbolo G.; Fanin R.; Lewis R.E.; Paris L.; Bonifazi F.; Cavo M.; Curti A.; Lemoli R.M. | 2020-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant | Papayannidis C.; Sartor C.; Dominietto A.; Zappone E.; Arpinati M.; Marconi G.; Cristiano G.; Nan...ni J.; Parisi S.; Barbato F.; Paolini S.; Soverini S.; Terragna C.; Robustelli V.; Testoni N.; Chirumbolo G.; Curti A.; Cavo M.; Bonifazi F. | 2021-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters | Parisi, Sarah; Ruggeri, Loredana; Dan, Elisa; Rizzi, Simonetta; Sinigaglia, Barbara; Ocadlikova, ...Darina; Bontadini, Andrea; Giudice, Valeria; Urbani, Elena; Ciardelli, Sara; Sartor, Chiara; Cristiano, Gianluca; Nanni, Jacopo; Zannoni, Letizia; Chirumbolo, Gabriella; Arpinati, Mario; Lewis, Russell E.; Bonifazi, Francesca; Marconi, Giovanni; Martinelli, Giovanni; Papayannidis, Cristina; Paolini, Stefania; Velardi, Andrea; Cavo, Michele; Lemoli, Roberto M.; Curti, Antonio | 2022-01-01 | FRONTIERS IN IMMUNOLOGY | - | 1.01 Articolo in rivista | frontiers in immunology.pdf |
| Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters | Parisi S.; Ruggeri L.; Dan E.; Rizzi S.; Sinigaglia B.; Ocadlikova D.; Bontadini A.; Giudice V.; ...Urbani E.; Ciardelli S.; Sartor C.; Cristiano G.; Nanni J.; Zannoni L.; Chirumbolo G.; Arpinati M.; Lewis R.E.; Bonifazi F.; Marconi G.; Martinelli G.; Papayannidis C.; Paolini S.; Velardi A.; Cavo M.; Lemoli R.M.; Curti A. | 2022-01-01 | FRONTIERS IN IMMUNOLOGY | - | 1.01 Articolo in rivista | Parisi et al. 2021 - Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells - Alloreactive NK Cell Dose Still Matters.pdf |
| Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment | Sartor C.; Arpinati M.; Chirumbolo G.; Dozza L.; Cristiano G.; Nanni J.; Marconi G.; Robustelli V....; Vigliotta I.; Parisi S.; Terragna C.; Testoni N.; Paolini S.; Martinelli G.; Curti A.; Cavo M.; Papayannidis C. | 2022-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation | Chirumbolo G.; Dicataldo M.; Barone M.; Storci G.; De Matteis S.; Laprovitera N.; Sinigaglia B.; ...Barbato F.; Maffini E.; Cavo M.; Bonifazi F.; Arpinati M. | 2023-01-01 | TRANSPLANTATION AND CELLULAR THERAPY | - | 1.01 Articolo in rivista | 1-s2.0-S2666636723011016-main.pdf; ScienceDirect_files_06Nov2023_14-08-57.071.zip |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile